Annexon, Inc. - Common Stock (ANNX)

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock
Shares outstanding
145,389,426
Total 13F shares
53,953,057
Share change
+5,812,379
Total reported value
$207,583,535
Put/Call ratio
20%
Price per share
$3.85
Number of holders
98
Value change
+$11,598,782
Number of buys
62
Number of sells
31

Institutional Holders of Annexon, Inc. - Common Stock (ANNX) as of Q1 2023

As of 31 Mar 2023, Annexon, Inc. - Common Stock (ANNX) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,953,057 shares. The largest 10 holders included Alerce Investment Management, L.P., Bain Capital Life Sciences Investors, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Redmile Group, LLC, VR Adviser, LLC, FEDERATED HERMES, INC., CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, and GMT CAPITAL CORP. This page lists 98 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.